/
To 31nd out more contact To 31nd out more contact

To 31nd out more contact - PDF document

bety
bety . @bety
Follow
342 views
Uploaded On 2022-08-27

To 31nd out more contact - PPT Presentation

enquiriescyprotexcom In vitro ADME PK Monoamine Oxidase MAO Inhibition Background Information 149 Monoamine oxidases MAO are membraneassociated enzymes located speci31cally to the out ID: 942450

inhibitor mao monoamine expressed mao inhibitor expressed monoamine speci enzyme substrate 146 clorgyline 149 kynuramine levels enzymes oxidase inhibition

Share:

Link:

Embed:

Download Presentation from below link

Download Pdf The PPT/PDF document "To 31nd out more contact" is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.


Presentation Transcript

To nd out more contact enquiries@cyprotex.com In vitro ADME & PK Monoamine Oxidase (MAO) Inhibition Background Information • Monoamine oxidases (MAO) are membrane-associated enzymes located specically to the outer mitochondrial membrane. They are the major enzymes participating in the catabolism of monoamine neurotransmitters and related exogenous amines. • Two isoforms of MAO exist, MAO-A and MAO-B, which differ in their substrate specicity, inhibitor selectivity and tissue distribution. • Selective MAO-A inhibitors are useful in the therapy of depression and anxiety whereas MAO-B inhibitors are often used in the treatment of Parkinson’s and Alzheimer’s • Cyprotex’s MAO inhibition assay identies if your compound is an inhibitor for either MAO-A or MAO-B. Protocol ‘In human brain the predominant form is MAO-B, expressed at highest levels in astrocytes and serotonergic neurons, while MAO-A is expressed at highest levels in catecholaminergic neurons.’ 1 Hotamisligil GS and Breakeeld XO (1991) Am J Hum Genet 49(2) ; 383–392 Substrate Kynuramine Metabolite 4-hydroxyquinolinol Test Article Concentrations 0, 0.4, 1, 4, 10, 40 and 100 µM (different concentrations av

ailable) Enzyme Source hMAO-A and hMAO-B expressed enzymes (Supersomes TM ) Test Article Requirements 100 µL of a 40 mM DMSO solution (or equivalent amount in solid) Positive Control Clorgyline MAO-A Selegiline MAO-B Analysis Method LC-MS/MS Data Delivery IC 50 Standard error of IC 50 % Control at each concentration Monoamine Oxidase (MAO) is a critical enzyme in the degradative deanimation of biogenic amines throughout the body 1 . Figure 1 Inhibitory specicity demonstrated for MAO-A inhibitor clorgyline using MAO-A or MAO-B expressed enzyme and kynuramine as the substrate. Figure 2 Inter-assay reproducibility of MAO-B inhibition using specic MAO-B inhibitor selegiline and non-specic inhibitor tranylcypromine. Each inhibitor was investigated on three separate occasions using hMAO-B expressed enzyme and kynuramine as substrate. The error bars represent the stadard error of the IC 50 determination. References 1 Hotamisligil GS and Breakeeld XO (1991) Human monoamine oxidase A gene determines levels of enzyme activity. Am J Hum Genet 49(2) ; 383-392 0.000010.00010.0010.010.11020406080100 120% ControlClorgyline concentration (Clorgyline MAO-A Clorgyline MAO-B 00.10.20.30.4 0.5IC 50 ( TranylcypromineSelegilineAssay 1Assay 2Assay 3